malondialdehyde has been researched along with Impotence, Arteriogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimitriadis, F; Inoue, S; Kinoshita, Y; Ohmasa, F; Saito, M; Satoh, K; Shimizu, S; Shomori, K; Tsounapi, P | 1 |
| Al-Matubsi, HY; Hamdan, FB | 1 |
2 other study(ies) available for malondialdehyde and Impotence, Arteriogenic
| Article | Year |
|---|---|
Edaravone ameliorates diabetes-induced dysfunction of NO-induced relaxation in corpus cavernosum smooth muscle in the rat.
Topics: Animals; Antipyrine; Blood Glucose; Cyclic GMP; Diabetes Mellitus, Experimental; Edaravone; Free Radical Scavengers; Impotence, Vasculogenic; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitric Oxide; Penis; Rats; Rats, Wistar; Reactive Oxygen Species; Vasodilation | 2011 |
Assessment of erectile dysfunction in diabetic patients.
Topics: Adolescent; Adult; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electrocardiography; Erectile Dysfunction; Glycated Hemoglobin; Gonadal Steroid Hormones; Humans; Impotence, Vasculogenic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Penis; Ultrasonography; Young Adult | 2009 |